Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Exp Eye Res. 2009 Jul 8;89(5):735–740. doi: 10.1016/j.exer.2009.06.017

Figure 6.

Figure 6

Fluorescence micrographs of normal (A), untreated rds (B), and EPO treated rds (C) retinas labeled with anti-GFAP (red) and DAPI (blue). GFAP labeling is present only in the Müller endfeet in the normal and EPO-treated rds retinas. In contrast, GFAP labeling is present in the Müller cell endfeet and in processes extending through the retina in the untreated rds retina.